There are contraindications! Be sure to consult your doctor before taking any medication!
Tricox consists of Isoniazid, Pyrazinamide, Rifampin.
Isoniazid - Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
Indication: For the treatment of all forms of tuberculosis in which organisms are susceptible.
Tricox (Isoniazid) is a bactericidal agent active against organisms of the genus Mycobacterium, specifically M. tuberculosis, M. bovis and M. kansasii. It is a highly specific agent, ineffective against other microorganisms. Tricox (Isoniazid) is bactericidal to rapidly-dividing mycobacteria, but is bacteriostatic if the mycobacterium is slow-growing.
Pyrazinamide - A pyrazine that is used therapeutically as an antitubercular agent.
Indication: For the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents.
Tricox (Pyrazinamide) kills or stops the growth of certain bacteria that cause tuberculosis (TB). It is used with other drugs to treat tuberculosis. It is a highly specific agent and is active only against Mycobacterium tuberculosis. In vitro and in vivo, the drug is active only at a slightly acid pH. Pyrazinamie gets activated to Pyrazinoic acid in the bacilli where it interferes with fatty acid synthase FAS I. This interferes with the bacteriums ability to synthesize new fatty acids, required for growth and replication.
Rifampin - A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Tricox (Rifampin) is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)
Indication: For the treatment of Tuberculosis and Tuberculosis-related mycobacterial infections.
Tricox (Rifampin) is an antibiotic that inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme. It is bactericidal and has a very broad spectrum of activity against most gram-positive and gram-negative organisms (including Pseudomonas aeruginosa) and specifically Mycobacterium tuberculosis. Because of rapid emergence of resistant bacteria, use is restricted to treatment of mycobacterial infections and a few other indications. Tricox (Rifampin) is well absorbed when taken orally and is distributed widely in body tissues and fluids, including the CSF. It is metabolized in the liver and eliminated in bile and, to a much lesser extent, in urine, but dose adjustments are unnecessary with renal insufficiency.
Pharmaceutical active ingredients containing related brand and generic drugs, medications or other health care products: